Suwen Su
Impact in
- Pharmacology top 10%
- Berberine and alkaloids research
- Plant-based Medicinal Research
-
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
Papers in
-
- Pharmacological Receptor Mechanisms and Effects 3
- Ion channel regulation and function 3
-
- Chemotherapy-induced cardiotoxicity and mitigation 8
- Cardiac electrophysiology and arrhythmias 4
- Co-authors
- Huicai Guo (6 shared papers)Xiong Chen (6 shared papers)Huanlong Liu (4 shared papers)Junxia Li (5 shared papers)Zhong‐ning Zhu (4 shared papers)Hiroshi Hibino (1 shared paper)Yukihiro Ohno (1 shared paper)Yoshihisa Kurachi (1 shared paper)
In The Last Decade
Suwen Su
33 papers receiving 576 citations
Peers
Comparison fields: 5 of 83
- Pharmacology 76
- Cancer Research 91
- Cardiology and Cardiovascular Medicine 130
- Pharmacology 80
- Biological Psychiatry 11
Countries citing papers authored by Suwen Su
This map shows the geographic impact of Suwen Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suwen Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suwen Su more than expected).
Fields of papers citing papers by Suwen Su
This network shows the impact of papers produced by Suwen Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suwen Su. The network helps show where Suwen Su may publish in the future.
Co-authors
The 25 scholars most cited alongside Suwen Su, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 83 | |
| 2 | 2006 | 60 | |
| 3 | 2013 | 56 | |
| 4 | 2019 | 49 | |
| 5 | 2018 | 46 | |
| 6 | 2013 | 40 | |
| 7 | Tert-butylhydroquinone ameliorates doxorubicin-induced cardiotoxicity by activating Nrf2 and inducing the expression of its target genes. | 2015 | 34 |
| 8 | 2013 | 30 | |
| 9 | 2012 | 26 | |
| 10 | 2020 | 20 | |
| 11 | 2018 | 20 | |
| 12 | 2022 | 16 | |
| 13 | 2023 | 15 | |
| 14 | 2023 | 15 | |
| 15 | 2011 | 14 | |
| 16 | 1998 | 10 | |
| 17 | 2023 | 7 | |
| 18 | 2024 | 6 | |
| 19 | 2024 | 5 | |
| 20 | 2022 | 5 |
About Suwen Su
Suwen Su is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine, Cancer Research, Oncology and Cellular and Molecular Neuroscience, having authored 35 papers that have together received 582 indexed citations. Recurring topics across this work include Chemotherapy-induced cardiotoxicity and mitigation (8 papers), Cardiac electrophysiology and arrhythmias (4 papers), Cancer, Lipids, and Metabolism (3 papers), Pharmacological Receptor Mechanisms and Effects (3 papers), Plant-based Medicinal Research (3 papers), Neuroscience and Neuropharmacology Research (3 papers), Ion channel regulation and function (3 papers) and Cancer, Hypoxia, and Metabolism (3 papers). The work is most often cited by research in Pharmacology (76 citations), Cancer Research (91 citations), Cardiology and Cardiovascular Medicine (130 citations), Pharmacology (80 citations) and Biological Psychiatry (11 citations). Suwen Su has collaborated with scholars based in China, Taiwan and Singapore. Frequent co-authors include Huicai Guo, Xiong Chen, Huanlong Liu, Junxia Li, Zhong‐ning Zhu, Hiroshi Hibino, Yukihiro Ohno, Yoshihisa Kurachi, Atsushi Inanobe and Christoph Lossin. Their work appears in journals such as Journal of Biochemical and Molecular Toxicology, Acta Pharmacologica Sinica, Cancer Biology & Therapy, Biomedicine & Pharmacotherapy and Journal of Pharmacology and Experimental Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.